IC
HUMA icon

IEQ Capital’s Humacyte HUMA Stock Holding History

IEQ Capital’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160K Buy
+264,319
New +$275K ﹤0.01% 1742
2025
Q3 		– Sell
-91,896
Closed -$192K – 1955
2025
Q2 		$192K Buy
+91,896
New +$177K ﹤0.01% 1621

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

IEQ Capital's HUMA Position: Q1 2026 in Review

IEQ Capital opened a new position in Humacyte (HUMA) in Q1 2026: 264,319 shares worth $160K. The stake represents ﹤0.01% of the portfolio and ranks #1742 among its holdings. This is a return to the name: IEQ Capital previously reported a position in HUMA as recently as Q2 2025.

IEQ Capital first reported a position in HUMA in Q2 2025 and has held it in 2 quarters since. The position peaked at $192K in Q2 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • IEQ Capital held 264,319 shares of Humacyte worth $160K as of Q1 2026.
  • Humacyte was a new IEQ Capital position in Q1 2026.
  • Humacyte made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1742 holding.
  • IEQ Capital first reported a position in Humacyte in Q2 2025 and has held it in 2 quarters since.
  • IEQ Capital's Humacyte position peaked at $192K in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.